Madrigal Pharmaceuticals, Inc.

MDGL

$430.17

Name : Madrigal Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $9,992,659,968.00

EPSttm : -5.85

Madrigal Pharmaceuticals, Inc.

$430.17

0.66%

$2.86

MDGL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.86

Margin Of Safety %

Put/Call OI Ratio

0.44

EPS Next Q Diff

-1.04

EPS Last/This Y

10.85

EPS This/Next Y

13.21

Price

432.64

Target Price

688.32

Analyst Recom

1.18

Performance Q

-14.65

Upside

-148.3%

Beta

-0.99

Ticker: MDGL

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	MDGL	452.2	0.41	1.80	14557
2026-10-14	MDGL	459.75	0.42	0.42	14824
2026-10-15	MDGL	459.83	0.42	0.40	15141
2026-10-16	MDGL	449.35	0.41	0.78	15141
2026-10-19	MDGL	447	0.47	0.14	11608
2026-10-20	MDGL	467.7	0.47	0.34	11737
2026-10-21	MDGL	458.12	0.46	0.14	11972
2026-10-22	MDGL	453.28	0.46	9.99	12007
2026-10-23	MDGL	433.83	0.47	0.19	12129
2026-10-26	MDGL	437.42	0.47	1.44	12195
2026-10-27	MDGL	440.75	0.47	1.42	12389
2026-10-28	MDGL	431.42	0.47	0.17	12387
2026-10-29	MDGL	431.59	0.47	3.17	12533
2026-10-30	MDGL	430.17	0.47	0.04	12583
2026-11-02	MDGL	430.83	0.47	2.90	12629
2026-11-03	MDGL	396.06	0.54	1.21	13515
2026-11-04	MDGL	400.73	0.46	0.22	14059
2026-11-05	MDGL	400.77	0.44	0.11	14952
2026-11-06	MDGL	400.24	0.43	1.30	15150
2026-11-09	MDGL	432.83	0.44	0.68	15327
2026-11-10	MDGL	433.6	0.44	0.96	15751
2026-11-11	MDGL	432.16	0.44	0.05	15795
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	MDGL	452.12	78.1	-	-6.49
2026-10-14	MDGL	459.90	78.1	-	-6.49
2026-10-15	MDGL	459.45	78.1	-	-6.49
2026-10-16	MDGL	449.75	78.1	-	-6.49
2026-10-19	MDGL	447.13	78.1	-	-6.49
2026-10-20	MDGL	447.13	78.1	-	-6.49
2026-10-21	MDGL	467.41	78.1	-	-6.49
2026-10-22	MDGL	453.25	78.1	-	-6.49
2026-10-23	MDGL	433.70	78.1	-	-6.49
2026-10-26	MDGL	437.42	78.1	-	-6.49
2026-10-27	MDGL	440.76	78.1	-	-6.49
2026-10-28	MDGL	431.22	78.1	-	-6.49
2026-10-29	MDGL	431.28	78.1	-	-6.49
2026-10-30	MDGL	430.16	78.1	-	-6.49
2026-11-02	MDGL	430.84	78.1	-	-6.49
2026-11-03	MDGL	396.06	78.1	-	-6.49
2026-11-04	MDGL	400.79	83.6	-	-6.49
2026-11-05	MDGL	400.54	83.6	-	-6.49
2026-11-06	MDGL	399.83	83.6	-	-6.49
2026-11-09	MDGL	432.81	83.6	-	-6.49
2026-11-10	MDGL	432.31	146.3	-	-2.00
2026-11-11	MDGL	432.64	174.7	-	-2.00
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	MDGL	-1.41	-1.80	11.13
2026-10-14	MDGL	-1.41	-1.80	11.13
2026-10-15	MDGL	-1.41	-1.80	11.13
2026-10-16	MDGL	-1.41	-1.80	11.13
2026-10-19	MDGL	-1.41	-1.76	11.13
2026-10-20	MDGL	-1.41	-1.76	11.13
2026-10-21	MDGL	-1.41	-1.76	11.13
2026-10-22	MDGL	-1.41	-1.76	11.13
2026-10-23	MDGL	-1.41	-1.76	11.13
2026-10-26	MDGL	-1.41	-2.74	11.13
2026-10-27	MDGL	-1.41	-2.74	10.19
2026-10-28	MDGL	-1.41	-2.74	10.19
2026-10-29	MDGL	-1.41	-2.74	10.19
2026-10-30	MDGL	-1.41	-2.74	10.19
2026-11-02	MDGL	-1.41	-2.75	10.19
2026-11-03	MDGL	-1.41	-2.75	10.19
2026-11-05	MDGL	-1.41	-2.75	10.19
2026-11-06	MDGL	-1.40	-2.75	10.19
2026-11-09	MDGL	4.55	-2.62	10.13
2026-11-10	MDGL	4.55	-2.62	10.13
2026-11-11	MDGL	4.55	-2.62	9.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.83

Avg. EPS Est. Current Quarter

1.92

Avg. EPS Est. Next Quarter

0.79

Insider Transactions

4.55

Institutional Transactions

-2.62

Beta

-0.99

Average Sales Estimate Current Quarter

477

Average Sales Estimate Next Quarter

460

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

29.7

Max Drawdown 5-Year %

-61.4

Target Price

688.32

P/E

Forward P/E

61.9

PEG

P/S

7.04

P/B

16.04

P/Free Cash Flow

EPS

-5.98

Average EPS Est. Cur. Y

-2

EPS Next Y. (Est.)

11.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-10.89

Relative Volume

0.84

Return on Equity vs Sector %

-51.2

Return on Equity vs Industry %

-31.6

EPS 1 7Days Diff

4.5

EPS 1 30Days Diff

4.49

EBIT Estimation

◆ MDGL Healthcare

$433.03

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

4/15

Valuation

15/20

TP/AR

3/10

Options

6/10

RSI

44.4

Range 1M

61.8%

Sup Dist

2.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

29/30

Estimates

3/20

Inst/Vol

0/15

Options

9/10

EPS Yr

84.3%

EPS NY

446.7%

52W%

30.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +10.1% upside

Quality

6/30

Valuation

4/30

Growth

22/25

Stability

6/10

LT Trend

0/5

Upside

+10.1%

Quality

MDGL — P/E HistoricalBiotechnology

Madrigal Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 915

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

MDGL

Latest News

—

Caricamento notizie per MDGL…

stock quote shares MDGL – Madrigal Pharmaceuticals Inc Stock Price stock today

news today MDGL – Madrigal Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDGL – Madrigal Pharmaceuticals Inc yahoo finance google finance

stock history MDGL – Madrigal Pharmaceuticals Inc invest stock market

stock prices MDGL premarket after hours

ticker MDGL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MDGL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y